Skip to content
healthcare.dev
Get a free key

Caladium Seguinum

NDC 63545-625, Caladium Seguinum, pellet, from Hahnemann Laboratories, INC..

Product NDC
63545-625
Status
Listed
Labeler
Hahnemann Laboratories, INC.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63545-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIEFFENBACHIA SEGUINE100 [hp_C]/1
Package NDCNDC-11Package
63545-625-0163545062501200 PELLET in 1 VIAL, GLASS (63545-625-01)
63545-625-0263545062502500 PELLET in 1 VIAL, GLASS (63545-625-02)
63545-625-03635450625033000 PELLET in 1 BOTTLE, GLASS (63545-625-03)
63545-625-046354506250410000 PELLET in 1 BOTTLE, GLASS (63545-625-04)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63545-625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63545-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63545-625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.